Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
40763480	hmpvag	— (—)	207	298	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Primary_lymphoid and hematopoietic malignant neoplasms

24.13

84.30

2.0

1.0

—

Transplanted organ and tissue status

39.60

76.81

2.6

1.3

—

Liquid cancers, helper endpoint

15.25

71.56

1.9

1.0

—

Bacterial infection, other or unspecified

11.30

69.27

1.7

1.2

—

Bacterial infection, other or unspecified

10.30

65.16

1.7

1.2

—

Fever of other and unknown origin

11.56

63.94

1.5

1.2

—

Other bacterial diseases

6.96

50.57

1.6

1.2

—

8.96

42.50

1.8

1.1

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

8.96

42.50

1.8

1.1

—

Other bacterial diseases

5.94

40.64

1.7

1.2

—

ILD medications: immunosuppressive drugs

7.22

38.97

2.1

1.1

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

5.87

38.39

1.8

1.1

—

Oxycodone

9.92

38.38

1.8

1.3

—

Implicit viral Sepsis

11.20

36.17

2.0

1.2

—

First line medication for Crohn's disease

5.61

34.88

1.7

1.2

—

5.71

34.64

1.4

1.1

—

Other septicaemia

9.19

34.21

1.8

1.3

—

Bronchitis

103

5.14

34.08

1.5

1.2

—

Pneumonia, organism unspecified

5.48

34.02

1.8

1.2

—

General symptoms and signs

6.27

32.59

1.5

1.2

—

Bacterial Sepsis

8.03

31.98

1.6

1.1

—

Septicaemia

7.93

31.55

1.8

1.3

—

Explicit Sepsis

7.38

30.39

1.8

1.2

—

COPD/asthma related infections

6.97

30.22

1.4

1.1

—

COPD/asthma/ILD related infections

6.97

30.22

1.4

1.1

—

Implicit bacterial Sepsis

8.46

30.19

1.6

1.1

—

Acute upper respiratory infections of multiple and unspecified sites

5.52

29.98

1.5

1.3

—

Influenza and pneumonia

103

4.82

29.74

1.8

1.2

—

Malignant neoplasm

6.02

28.87

1.8

1.1

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

109

4.69

28.63

1.9

1.2

—

ILD medications

4.78

28.54

1.8

1.1

—

Implicit Sepsis

5.57

28.09

1.6

1.2

—

Pneumonias (Asthma/COPD co-morbidities)

109

4.62

27.97

1.9

1.2

—

Implicit bacterial Sepsis

7.54

27.24

1.6

1.1

—

All pneumoniae

109

4.54

27.00

1.9

1.2

—

Acute upper respiratory infections

101

4.45

25.25

1.4

1.3

—

Any event in cancer register

5.16

24.98

1.8

1.2

—

Acute sinusitis

6.23

24.84

1.6

1.3

—

Multiple myeloma, including Hilmo

+∞

24.01

1.5

0.0

—

ILD medications: prednisolone, methylprednisolone, prednisone

4.46

23.65

1.8

1.1

—

Implicit Sepsis

4.74

23.47

1.6

1.2

—

Malignant neoplasm, wide definition for exclusion

5.14

22.54

1.9

1.1

—

Certain infectious and parasitic diseases

5.74

22.30

1.6

1.1

—

All influenza

7.91

22.11

2.2

1.2

—

Cough

5.57

20.88

1.5

1.4

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

+∞

19.85

1.5

0.0

—

Multiple myeloma

+∞

19.85

1.5

0.0

—

Condition for Implicit Sepsis (Organ dysfunction codes)

4.24

19.68

1.7

1.2

—

L04AX Other immunosuppressants

105

4.48

19.53

1.4

1.3

—

Other diseases of blood and blood-forming organs, wide

7.90

19.13

2.2

1.4

—

Second line medication for Crohn's disease

107

4.40

19.08

1.4

—

Other pulmonary diagnosis

6.38

18.64

1.4

1.1

—

COPD differential diagnosis

6.38

18.63

1.4

1.1

—

ILD differential diagnosis

6.38

18.63

1.4

1.1

—

Excluding asthma or asthma-COPD overlap

6.23

17.85

1.4

1.1

—

Headache

5.38

17.50

1.3

1.2

—

Implicit viral Sepsis

13.22

16.90

2.1

1.0

—

Viral Sepsis

13.22

16.90

2.1

1.0

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

130

3.40

16.36

1.8

1.3

—

Solid cancers, helper endpoint

4.61

16.35

1.6

1.1

—

Other acute lower respiratory infections

111

3.95

16.08

1.6

1.4

—

Certain infectious and parasitic diseases

5.75

15.91

1.4

1.1

—

Inflammatory bowel disease treatment related agents

117

3.30

15.75

1.5

1.4

—

Complications of medical and surgical care

126

3.65

15.50

1.5

1.3

—

Acute bronchitis

4.43

15.12

1.5

1.4

—

GASTRO-related operations

4.90

14.46

1.3

—

Any gastric operation

4.90

14.46

1.3

—

Condition for Implicit Sepsis (Organ dysfunction codes)

3.63

14.37

1.7

1.2

—

Oral corticosteroids

110

3.29

14.20

1.4

1.3

—

Viral infections characterized by skin and mucous membrane lesions

145

3.24

14.03

1.8

1.3

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

106

3.72

13.92

1.5

1.3

—

Other and unspecified disorders of skin and subcutaneous tissue

25.87

13.36

1.6

1.4

—

Abnormal findings on diagnostic imaging of lung

4.11

13.33

1.6

1.2

—

Non-Hodgkin lymphoma, all, including Hilmo

19.06

12.89

1.7

1.0

—

Viral infections characterized by skin and mucous membrane lesions

4.18

12.64

1.6

1.5

—

Asthma, unspecified (mode)

5.83

12.05

1.3

1.1

—

Asthma, unspecified (mode), excluding more controls

5.94

11.71

1.3

1.1

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

111

3.47

11.52

1.5

1.3

—

Diseases of the respiratory system

6.60

11.45

1.4

1.1

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

15.03

11.28

1.7

1.0

—

Enlarged lymph nodes

17.03

11.17

2.0

1.8

—

General examination and investigation of persons without complaint and reported diagnosis

4.05

11.17

1.4

1.3

—

Lymphoid leukaemia

20.13

11.13

1.6

1.4

—

Diarrhoea and gastroenteritis of presumed infectious origin

136

2.81

10.92

1.7

1.2

—

Secondary uncertain malignant neoplasm

15.50

10.81

1.7

1.0

—

Neoplasms

3.59

10.70

1.6

1.2

—

Anaemias

11.44

10.57

2.3

1.0

—

Non-Hodgkin lymphoma, all

+∞

10.42

2.0

0.0

—

Any reimbursement code in KELA

4.57

10.26

1.5

1.1

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

8.77

10.25

1.5

1.2

—

Medical observation and evaluation for suspected diseases and conditions

3.86

10.21

1.5

1.3

—

Renal tubulo-interstitial diseases

127

2.87

9.96

1.7

1.4

—

Fitting and adjustment of other devices

4.13

9.95

1.1

1.4

—

Any death

3.44

9.91

1.5

1.4

—

Complications of surgical and medical care, not elsewhere classified

135

2.74

9.85

1.4

1.3

—

Diarrhoea and gastroenteritis of presumed infectious origin

135

2.94

9.76

1.6

1.3

—

Malignant neoplasm of breast, HER2-negative

5.33

9.58

1.0

—

Intestinal infectious diseases

150

2.68

9.57

1.7

1.3

—

Caries of dentine

8.12

9.34

2.4

1.4

—

Other disorders of skin and subcutaneous tissue

123

2.96

9.22

1.3

—

Malignant neoplasm of breast

5.13

9.21

1.0

—

Dental caries

6.83

9.17

2.5

1.4

—

Osteopathies and chondropathies

102

3.20

9.05

1.5

1.4

—

Tramadol

3.40

9.04

1.0

1.2

—

L04AD Calcineurin inhibitors

10.03

9.01

3.4

1.4

—

Renal failure

3.47

8.97

2.3

1.3

—

Asthma (mode)

4.38

8.83

1.3

1.1

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

4.91

8.80

1.0

—

Malignant neoplasm of breast, including Hilmo

4.91

8.80

1.0

—

All kidney diseases

132

2.64

8.73

1.8

1.3

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

4.14

8.73

1.6

1.3

—

Gastro-oesophageal reflux disease

114

2.95

8.68

1.4

1.3

—

Asthma

4.29

8.56

1.3

1.1

—

Asthma (only as main-diagnosis)

4.39

8.47

1.2

1.1

—

Chronic lymphocytic leukaemia

+∞

8.34

1.3

0.0

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

+∞

8.34

1.3

0.0

—

Chronic lymphocytic leukaemia, helper endpoint

+∞

8.34

1.3

0.0

—

ILD medications: azathioprine

10.73

8.28

1.3

—

Asthma (only as main-diagnosis), excluding more controls

4.43

8.18

1.3

1.1

—

Pain in joint

3.40

8.17

1.2

1.5

—

Follow-up examination after treatment for conditions other than malignant neoplasms

4.04

8.11

1.6

1.4

—

Non-follicular lymphoma

11.70

8.06

1.2

1.3

—

Implicit fungal Sepsis

22.08

8.01

2.1

1.0

—

Other problems related to primary support group, including family circumstances

7.31

7.97

1.7

1.3

—

Fentanyl

13.01

7.86

1.2

1.0

—

Asthma, excluding more controls

4.21

7.75

1.3

1.1

—

Acute pharyngitis

8.36

7.75

1.6

1.2

—

Nausea and vomiting

3.85

7.61

1.2

1.3

—

ILD, hospital admission 2, with pulmonary infections

18.37

7.59

1.5

1.0

—

Opioids

2.79

7.54

1.5

1.2

—

Malaise and fatigue

3.94

7.40

1.7

1.3

—

All chronic kidney diseases

3.09

7.40

1.8

1.4

—

Mycoses

4.13

7.26

2.2

1.2

—

Persons encountering health services for specific procedures and health care

133

2.39

7.24

1.2

1.6

—

Acute tubulo-interstitial nephritis

112

2.77

7.23

1.2

1.4

—

Intestinal infectious diseases

137

2.34

7.19

1.8

1.2

—

Other diseases of urinary system

115

2.44

7.04

1.5

—

Other and unspecified anaemias

3.26

7.03

2.3

1.3

—

Other anaemias

3.25

7.00

2.3

1.3

—

Depression medications

5.70

6.98

1.1

1.0

—

Anxiety disorders, excluding more controls

105

2.60

6.98

1.5

—

Diseases of middle ear and mastoid

2.87

6.97

1.3

1.4

—

ILD, hospital admissions 3, with pneumonia sepsis

16.71

6.74

1.5

1.0

—

Other special examinations and investigations of persons without complaint or reported diagnosis

3.20

6.73

1.3

—

Azathioprine

7.15

6.69

1.3

1.8

—

Neurotic, stress-related and somatoform disorders

123

2.45

6.47

1.5

1.4

—

Erysipelas

3.12

6.46

1.1

1.2

—

Coagulation defects, purpura and other haemorrhagic conditions

5.30

6.44

2.1

1.4

—

Benzodiazepine use

143

2.31

6.38

1.3

1.4

—

Aplastic and other anaemias

3.00

6.36

2.2

1.3

—

Codeine

2.68

6.36

1.2

—

Myeloid leukaemia

18.14

6.27

4.4

1.0

—

Aspergillosis

+∞

6.27

2.7

0.0

—

Diseases of the digestive system

2.92

6.19

1.4

—

Gastrointestinal diseases

3.16

6.17

1.7

1.1

—

Zoster [herpes zoster]

2.98

6.14

1.9

1.2

—

Codes for special purposes

115

2.69

6.13

1.4

1.3

—

Provisional assignment of new diseases of uncertain etiology

115

2.69

6.13

1.4

1.3

—

Osteoporosis

3.83

6.12

1.2

1.1

—

Anxiety disorders

126

2.38

6.11

1.5

1.4

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

133

2.21

6.09

1.4

1.5

—

Dental operations

3.10

6.07

1.1

1.3

—

Mycoses

151

2.36

6.04

1.6

1.3

—

Diseases of oral cavity, salivary glands and jaws

3.13

5.95

1.4

1.3

—

Chronic kidney disease

3.44

5.95

2.1

1.2

—

Parasetamol

2.73

5.92

1.2

1.6

—

Agranulocytosis

7.24

5.91

2.1

1.0

—

Other and unspecified tonsillitis

3.97

5.89

2.2

1.6

—

Hypothyroidism (congenital or acquired)

7.06

5.89

1.6

1.0

—

Other diseases of the digestive system

3.28

5.84

1.5

—

Erysipelas

3.24

5.83

1.1

1.2

—

Genitourinary diseases

3.03

5.81

1.4

1.5

—

Bleeding

124

2.35

5.74

1.6

1.4

—

Missing teeth due to accident, extraction or parodontitis

101

2.71

5.74

1.4

1.3

—

Other viral diseases, not elsewhere classified

3.44

5.66

2.0

1.5

—

Chronic periodontitis, complicated

2.83

5.66

1.5

1.4

—

Oedema, not elsewhere classified

5.09

5.61

1.4

—

Other viral diseases

2.94

5.58

2.2

1.3

—

Other disorders of white blood cells

12.90

5.58

2.7

1.0

—

Undetermined asthma

12.86

5.57

1.7

1.1

—

Undetermined asthma, excluding more controls

12.86

5.57

1.7

1.1

—

Other disorders of fluid, electrolyte and acid-base balance

3.42

5.55

1.1

1.4

—

Enterocolitis due to Clostridium difficile

8.48

5.55

2.2

1.0

—

Acute renal failure

4.60

5.47

2.4

1.3

—

Mood disorders, excluding more controls

112

2.29

5.46

1.3

1.4

—

Diseases of external ear

3.23

5.43

1.3

1.4

—

GI-bleeding

3.23

5.43

1.5

—

Other joint disorders

101

2.30

5.43

1.3

1.6

—

Implicit fungal Sepsis

16.08

5.41

2.5

1.0

—

Fungal Sepsis

16.08

5.41

2.5

1.0

—

Complications of procedures, not elsewhere classified

125

2.38

5.39

1.0

1.3

—

Symptoms and signs involving the circulatory and respiratory systems

2.30

5.34

1.4

1.5

—

Persons encountering health services in other circumstances, wide

133

2.09

5.32

1.3

1.5

—

Diseases of the ear and mastoid process

116

2.16

5.32

1.3

1.4

—

Syncope and collapse

3.50

5.31

1.2

1.3

—

Pain in throat and chest

2.46

5.31

1.3

1.4

—

Hypothyroidism and >3 levothyroxin purchases

7.35

5.29

1.7

1.0

—

Hypothyroidism, levothyroxine purchases

7.35

5.29

1.7

1.0

—

Infections, IBD-co-morbidities

5.89

5.22

2.7

1.2

—

Mature T/NK-cell lymphomas, hilmo

+∞

5.22

2.6

0.0

—

Nonsuppurative otitis media

3.59

5.21

1.5

1.6

—

Myelodysplastic syndrome, including Hilmo

+∞

5.21

2.2

0.0

—

Diffuse large B-cell lymphoma, including Hilmo

+∞

5.21

1.4

0.0

—

Diffuse large B-cell lymphoma

+∞

5.21

1.4

0.0

—

Diffuse large B-cell lymphoma, helper endpoint

+∞

5.21

1.4

0.0

—

Episodal and paroxysmal disorders

119

2.14

5.20

1.4

1.5

—

Anxiety (asthma-related co-morbidities)

2.52

5.16

1.6

1.5

—

Lyme disease

3.47

5.16

1.0

1.4

—

DVT of lower extremities and pulmonary embolism

2.86

5.13

1.4

—

L01XX Other antineoplastic agents

13.38

5.08

1.4

1.5

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

6.33

5.07

2.7

1.2

—

Purpura and other haemorrhagic conditions

5.66

5.05

2.2

1.5

—

Periodontitis

124

2.21

4.97

1.3

1.4

—

Cystitis

102

2.27

4.90

1.3

1.5

—

Other viral diseases

3.11

4.87

2.4

1.3

—

Spirochaetal infections, other/unspecified

3.34

4.87

1.0

1.4

—

Candidiasis

3.34

4.87

1.5

1.1

—

Malignant neoplasm of skin

3.43

4.84

1.3

1.0

—

All anxiety disorders

101

2.43

4.80

1.6

1.4

—

Other diseases of upper respiratory tract

123

2.08

4.80

1.1

1.5

—

Mood [affective] disorders

139

2.10

4.79

1.2

1.4

—

L01XE Protein kinase inhibitors

11.47

4.78

2.3

1.4

—

Malignant neoplasm of breast, HER-positive

4.68

4.78

1.1

1.0

—

Symptoms and signs concerning food and fluid intake

11.43

4.77

1.1

2.1

—

Chronic apical periodontitis

136

2.05

4.77

1.3

1.4

—

Mood disorders

139

2.09

4.77

1.2

1.4

—

Migraine

2.74

4.75

1.1

1.3

—

Other spirochaetal diseases

3.27

4.74

1.0

1.4

—

Other spirochaetal diseases

3.27

4.74

1.0

1.4

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

121

2.17

4.73

1.2

1.4

—

Malignant neoplasm of breast, ER-positive, including Hilmo

4.63

4.73

1.1

1.0

—

Symptoms and signs involving the skin and subcutaneous tissue

141

2.29

4.72

1.2

1.4

—

Neurological diseases

2.28

4.70

1.4

1.7

—

Any mental disorder

119

2.06

4.67

1.3

1.5

—

Injuries to the shoulder and upper arm

146

2.15

4.65

1.5

1.4

—

Other functional intestinal disorders

2.61

4.65

1.5

—

Superficial injury of shoulder and upper arm

7.15

4.65

1.3

1.0

—

Other heart diseases

2.72

4.62

2.1

1.4

—

Covid-19 suspected case

3.49

4.60

1.7

1.4

—

Conjunctivitis (acute, non atopic)

3.09

4.59

2.0

1.4

—

All influenza (not pneumonia)

5.46

4.59

2.8

1.3

—

Hypoparathyroidism

14.06

4.58

1.4

1.0

—

Heart failure, not strict

2.33

4.56

1.6

1.4

—

Thrombocytopenia, unspecified

8.20

4.56

2.6

1.3

—

Other diseases of hard tissues of teeth

2.81

4.55

1.4

1.3

—

Chronic periodontitis, including avohilmo

125

2.14

4.55

1.3

1.4

—

Symptoms and signs involving the digestive system and abdomen

107

2.11

4.54

1.7

1.4

—

Disorders of calcium metabolism

10.03

4.52

1.5

1.0

—

Triptan medication for migraine, single purchase ok

105

2.26

4.50

1.4

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

105

2.26

4.50

1.4

—

Other bacterial intestinal infections

4.82

4.49

2.4

1.0

—

Chronic sinusitis

2.86

4.47

1.2

1.5

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

123

2.36

4.45

1.0

1.3

—

Depression or dysthymia

2.37

4.45

1.3

1.4

—

Presence of other functional implants

2.91

4.44

1.3

1.1

—

Diseases of the skin and subcutaneous tissue

105

2.10

4.43

1.4

—

Cellulitis

4.06

4.39

1.3

1.5

—

Other anxiety disorders

2.66

4.38

1.2

1.4

—

Bacterial pneumoniae

3.05

4.38

1.7

1.2

—

Bacterial intestinal infections, IBD co-morbidities

4.65

4.36

2.4

1.0

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

5.02

4.33

1.6

1.1

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

7.09

4.32

1.5

1.1

—

Continuous positive airway pressure

4.37

4.31

1.2

1.7

—

Nutritional anaemias

2.48

4.28

1.6

1.3

—

Other respiratory diseases principally affecting the interstitium

4.49

4.24

1.4

—

Other specific joint derangements/joint disorders

2.24

4.16

1.2

1.6

—

DVT of lower extremities

4.34

4.12

1.1

1.6

—

Bacterial pneumonia (organism specified)

2.54

4.09

1.7

1.4

—

Other viral diseases, not elsewhere classified

3.33

4.02

2.3

1.5

—

ILD, hospital admissions

5.01

4.00

1.5

—

Other interstitial pulmonary diseases

5.01

4.00

1.5

—

Interstitial lung disease endpoints

5.01

4.00

1.5

—

Interstitial lung disease

5.01

4.00

1.5

—

Other reaction to severe stress, and adjustment disorders

2.81

3.94

1.8

1.2

—

Localized swelling, mass and lump of skin and subcutaneous tissue

2.88

3.89

1.2

1.4

—

Drug-induced neutropenia

7.29

3.86

2.6

1.3

—

Myeloproliferative diseases

7.29

3.86

3.4

1.3

—

Bronchiectasis

6.01

3.81

1.1

1.3

—

External causes of morbidity and mortality

2.31

3.79

1.7

1.6

—

Depression

137

1.98

3.76

1.3

1.4

—

Immunodeficiencies

12.03

3.76

1.2

1.0

—

Unspecified acute lower respiratory infection

4.59

3.74

1.5

—

Other neurological diseases

119

2.11

3.69

1.4

1.3

—

Other bacterial intestinal infections

3.59

3.69

2.3

1.2

—

Herpesviral [herpes simplex] infections

3.59

3.69

1.1

1.3

—

ILD, hospital admissions 1, main diag only

5.01

3.68

1.0

1.6

—

Chronic laryngitis and laryngotracheitis

5.01

3.68

1.0

1.9

—

Cardiovascular diseases

2.29

3.68

1.9

1.3

—

Family history of malignant neoplasm

6.67

3.67

1.0

1.1

—

Examination and observation for other reasons

2.60

3.66

1.4

1.3

—

Other heart diseases, wide

124

1.97

3.66

1.8

1.4

—

L04AA Selective immunosuppressants

3.50

3.60

2.6

1.3

—

Codeine or tramadol medication

130

1.89

3.58

1.2

1.4

—

Presence of other devices

3.99

3.57

1.0

1.1

—

Explicit bacterial Sepsis

7.78

3.55

1.1

1.0

—

Infections of the skin and subcutaneous tissue

129

2.15

3.53

1.1

1.6

—

Neurological diseases, wide definition

3.05

3.52

1.4

1.5

—

Herpesviral [herpes simplex] infections

5.30

3.50

1.2

1.6

—

Budesonide

5.30

3.50

1.6

1.8

—

Kidney transplant status

10.02

3.50

2.8

1.0

—

Arthropathies

103

1.97

3.48

1.3

1.6

—

Coxibs

4.03

3.46

1.0

1.5

—

Other diseases of lip and oral mucosa

2.53

3.45

1.3

1.4

—

Exposure to other specified factors

151

2.01

3.45

1.8

1.4

—

Tonsillectomy and adenotomy

2.26

3.45

1.6

1.4

—

Other specified/unspecified arthritis

2.98

3.40

1.6

1.5

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

3.03

3.40

1.4

1.0

—

Other soft tissue disorders, not elsewhere classified

122

1.92

3.39

1.5

1.4

—

Otitis externa

3.10

3.36

1.4

1.5

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

2.83

3.35

1.4

—

Triptan medication for migraine, min. 3 purchases

2.29

3.34

1.5

1.2

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

2.99

3.34

1.4

1.0

—

Menorrhagia

2.86

3.31

1.2

1.1

—

Disease of hard tissues of teeth, NOS

2.62

3.29

1.3

—

Zoster [herpes zoster]

3.93

3.28

1.3

1.4

—

Diseases of the musculoskeletal system and connective tissue

2.26

3.28

1.5

1.7

—

Follow-up care involving plastic surgery

8.60

3.26

1.0

—

Diseases of tongue

8.59

3.26

1.5

1.0

—

Diseases of pulp and periapical tissues, including avohilmo

127

1.84

3.25

1.3

1.4

—

FESS (DNB20)

4.74

3.23

1.1

1.6

—

Ethmoidectomy

4.74

3.23

1.1

1.6

—

Dyspnoea

139

1.91

3.19

1.5

1.3

—

Other necrotizing vasculopathies

6.38

3.18

1.6

1.3

—

Special screening examination for infectious and parasitic diseases

3.68

3.18

1.0

1.2

—

Venous thromboembolism

106

2.19

3.17

1.5

1.4

—

Diseases of oesophagus, stomach and duodenum

137

1.83

3.14

1.5

1.3

—

Abnormalities of breathing

2.00

3.13

1.6

1.5

—

Excessive, frequent and irregular menstruation

2.67

3.11

1.2

1.1

—

Delayed milestone in childhood

6.34

3.11

2.1

2.4

—

Chronic pancreatitis

4.51

3.11

1.0

1.8

—

Sleep apnoea

122

1.91

3.10

1.2

1.4

—

Acute pancreatitis

3.67

3.08

1.7

1.6

—

Speech and linguistic disorders, excluding more controls

4.46

3.06

1.6

—

Giant cell arteritis

7.52

3.05

1.7

1.4

—

Osteonecrosis

7.52

3.05

1.2

1.4

—

Disorders of mineral metabolism

5.01

3.05

1.5

1.6

—

Care involving dialysis

5.84

3.02

1.3

1.9

—

Other puerperal infections

5.84

3.02

1.3

1.0

—

Other disorders of bone

3.34

3.01

1.8

1.5

—

Glomerular diseases

3.55

2.98

1.8

1.5

—

Nephrotic syndrome

10.03

2.98

2.8

1.0

—

Disorders of lens

2.14

2.98

2.0

1.3

—

Streptococcal septicaemia

10.01

2.98

1.2

1.0

—

Ventricular septal defect, a heart condition

10.02

2.97

1.8

1.4

—

Acetic acid derivatives and related substances

3.67

2.97

1.0

1.5

—

Iron deficiency anaemia

2.29

2.97

1.2

1.3

—

Diseases of the eye and adnexa

2.00

2.96

1.5

1.4

—

Factors influencing health status and contact with health services

5.02

2.96

2.2

1.0

—

Polycystic ovarian syndrome, consortium definition

2.10

2.95

1.0

1.1

—

Later onset COPD, excluding more controls

6.01

2.94

1.9

1.1

—

Viral pneumonia

4.71

2.91

2.0

1.2

—

Haemorrhage from respiratory passages

2.74

2.91

1.3

1.4

—

Other skin changes

3.44

2.89

1.3

1.4

—

Acute pancreatitis (for exclusion)

3.44

2.89

1.7

1.4

—

Noninflammatory disorders of female genital tract

2.51

2.88

1.2

1.1

—

Nephropathy related operations

4.10

2.88

2.2

1.5

—

Chronic diseases of tonsils and adenoids

100

1.96

2.87

1.4

1.6

—

Disorders of other endocrine glands

100

2.16

2.87

1.8

1.3

—

Hypercalcemia

6.69

2.87

1.7

1.0

—

Spirochaetal infections, other/unspecified

5.39

2.87

1.0

1.3

—

Other infective otitis externa

6.68

2.87

1.0

1.3

—

Acute suppurative otitis media

2.59

2.84

1.8

1.4

—

Abdominal and pelvic pain

107

1.83

2.82

1.8

1.4

—

Myalgia

2.77

2.81

1.2

—

Non-invasive ventilation

3.39

2.81

1.5

1.7

—

Gingivitis and periodontal diseases

118

1.79

2.80

1.5

1.3

—

Other disorders of lacrimal gland

2.40

2.79

1.6

1.3

—

Hypokalaemia

3.92

2.77

1.0

1.4

—

Candidiasis

3.92

2.77

1.9

1.2

—

ILD-related respiratory insufficiency

8.36

2.75

1.0

1.5

—

Giant cell arteritis with polymyalgia rheumatica

8.36

2.75

1.8

1.0

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

8.35

2.75

1.6

1.0

—

Meningitis

8.35

2.75

1.6

1.0

—

Senile cataract

2.17

2.74

1.9

1.4

—

Viral warts

5.01

2.72

2.4

1.8

—

Persons encountering health services for examination and investigation

2.25

2.70

1.5

1.3

—

Tongue abnormality

6.01

2.70

1.5

1.0

—

Other necrotizing vasculopathies (FG)

6.01

2.70

1.7

1.3

—

Personal history of malignant neoplasm

6.01

2.70

1.5

1.1

—

Other postsurgical states

6.01

2.69

1.3

1.4

—

Hernia of abdominal wall, postoperative

6.00

2.69

1.2

1.5

—

Hypertrophy of breast in women and men

3.45

2.68

1.2

1.4

—

COPD (mode)

3.93

2.68

1.9

1.1

—

Disorders of lacrimal system

2.23

2.68

1.5

1.2

—

Glomerulonephritis

4.22

2.67

2.1

1.6

—

COPD-related respiratory insufficiency

4.22

2.67

2.0

1.2

—

Migraine with aura and triptan purchases

3.75

2.67

1.0

1.2

—

Antihypertensive medication - note that there are other indications

2.01

2.66

1.6

1.3

—

Medicines for HER+ breast cancer

2.49

2.65

1.1

—

Conduction disorders

2.53

2.65

1.1

1.5

—

Peripheral artery disease

2.26

2.64

1.3

1.4

—

L02BG Aromatase inhibitors

2.65

2.61

1.1

—

Low back pain

114

1.89

2.60

1.0

1.5

—

Other medical care

2.22

2.60

1.2

1.5

—

Disorders of the thyroid gland

131

1.79

2.60

1.4

—

Other nutritional deficiencies

119

1.98

2.59

1.2

1.4

—

Faecal incontinence

4.67

2.59

1.3

1.1

—

Impacted cerumen

4.67

2.59

1.0

1.3

—

Diaphragmatic hernia

2.30

2.57

1.2

1.4

—

Other antidepressants

113

1.77

2.57

1.5

1.4

—

Other diseases of intestines

135

1.73

2.56

1.5

—

Sleep apnoea, including avohilmo

125

1.78

2.55

1.2

1.5

—

Temporal arteritis

7.17

2.55

1.8

1.4

—

Gingival hyperplasia

7.17

2.55

1.6

1.4

—

Viral pneumonia (unknown virus, not influenza)

5.46

2.54

2.0

—

Eustachian salpingitis and obstruction

5.46

2.54

1.0

1.7

—

Urticaria and erythema

2.22

2.53

1.8

1.4

—

Atherosclerosis, excluding cerebral and coronary sclerosis

2.26

2.52

1.3

1.4

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

3.23

2.51

1.9

1.1

—

Covid-19 confirmed case

2.27

2.50

1.2

1.3

—

Malignant neoplasm of prostate, including Hilmo

3.82

2.50

1.7

1.0

—

Pain (limb, back, neck, head abdominally)

1.94

2.49

1.8

1.5

—

Hypoplasia of dental enamel , including avohilmo

5.31

2.48

2.8

2.2

—

Constipation

142

1.75

2.48

1.2

1.5

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

4.38

2.47

1.3

1.7

—

Pruritus

4.38

2.47

1.1

1.3

—

Heart failure,strict

2.12

2.46

1.5

1.4

—

Obesity

118

1.96

2.46

1.1

1.4

—

Speech and linguistic disorders

3.46

2.46

1.6

1.8

—

Dialysis, with operation codes

3.81

2.46

2.3

1.4

—

Recurrent or chronic depression

2.26

2.45

1.5

1.4

—

Disorders of parathyroid gland

2.94

2.44

1.3

1.1

—

Cardiovascular diseases (excluding rheumatic etc)

1.94

2.42

2.0

1.3

—

Septal defects

4.29

2.42

2.4

2.1

—

Asthma-related pneumonia

2.23

2.42

1.4

1.3

—

Asthma-related pneumonia or sepsis

2.23

2.42

1.4

1.3

—

Asthma, hospital admissions 3, pneumonia

2.23

2.42

1.4

1.3

—

Dorsalgia

117

1.74

2.42

1.1

1.5

—

Acute bronchiolitis

3.80

2.42

2.8

1.8

—

Substance use, excluding alcohol

2.90

2.41

1.0

1.3

—

Metabolic disorders

121

1.76

2.41

1.4

—

Bacterial pneumonia, not elsewhere classified

2.47

2.40

1.1

1.2

—

Obesity and other hyperalimentation

119

1.94

2.40

1.1

1.4

—

Astigmatism

5.00

2.40

2.0

1.3

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

4.99

2.39

1.2

1.0

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

131

1.75

2.39

1.4

1.3

—

Injury, poisoning and certain other consequences of external causes

2.12

2.39

1.8

1.7

—

Acute gastritis

6.26

2.37

1.0

—

Other or ill-defined heart diseases

6.26

2.37

1.4

2.0

—

Otitis media, unspecified

3.69

2.36

2.1

1.0

—

Otitis externa, unspecified

4.12

2.36

1.7

—

Transport accidents

2.12

2.35

1.2

1.5

—

Focal epilepsy, strict definition

2.82

2.33

1.5

1.6

—

Used for control exclusion in common control thyroid runs

119

1.70

2.32

1.7

1.5

—

Malignant neoplasm of breast, HER-negative

3.57

2.31

1.0

—

Other disorders of urethra and urinary system

1.92

2.30

1.6

1.3

—

Other symptoms and signs involving the digestive system and abdomen

3.22

2.30

1.2

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

117

1.79

2.29

1.4

1.2

—

Symptoms and signs involving the urinary system

133

1.78

2.29

1.3

1.4

—

Suppurative and unspecified otitis media

2.25

2.28

1.7

1.4

—

Migraine without aura

2.94

2.27

1.0

1.5

—

Dental pulpitis, including avohilmo

122

1.76

2.27

1.5

1.4

—

Fibrosis and cirrhosis of liver

4.62

2.27

1.0

1.3

—

Early onset COPD, excluding more controls

4.61

2.27

1.3

1.2

—

Other CVD

2.75

2.27

1.1

1.4

—

Cholecystitis

3.48

2.26

1.0

1.5

—

Other headache syndromes

2.22

2.26

1.4

—

Pain in limb

117

1.77

2.22

1.6

1.4

—

Persistent mood disorders

3.11

2.22

2.0

1.4

—

Pain, not elsewhere classified

3.10

2.22

1.2

1.3

—

Extracorporeal dialysis

5.56

2.21

1.4

1.3

—

Myeloproliferative diseases (CML excluded)

5.56

2.21

2.6

1.3

—

Polyuria

2.68

2.20

1.3

1.6

—

Molar incisor enamel hypoplasia

4.46

2.20

2.8

2.0

—

Use of hypnotics and sedatives

130

1.68

2.20

1.3

1.4

—

Accidents

1.78

2.19

1.6

—

Disorders of conjunctiva

149

1.72

2.17

1.6

1.4

—

Other arthritis (FG)

2.24

2.17

1.6

1.4

—

Hypothyroidism, other/unspecified

126

1.72

2.15

1.4

1.3

—

Malignant neoplasm of breast, ER-negative, including Hilmo

3.31

2.15

1.0

—

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

4.29

2.15

1.3

1.9

—

Bacterial, viral and other infectious agents

4.29

2.15

3.2

1.6

—

Infectious mononucleosis

3.69

2.15

1.6

1.4

—

Benign neoplasm of breast

3.69

2.15

1.0

1.1

—

Other embolism and thrombosis

3.69

2.15

1.1

1.6

—

Disorders of sclera, cornea, iris and ciliary body

115

1.91

2.14

1.5

1.3

—

Hypothyroidism, strict autoimmune

1.83

2.14

1.4

1.3

—

Other abnormal uterine and vaginal bleeding

2.72

2.14

1.0

1.1

—

Nasal polyp

3.00

2.14

1.1

1.9

—

Disorders of psychological development

2.81

2.14

2.0

1.9

—

Heart failure and coronary heart disease

2.07

2.14

1.1

1.6

—

Hypotension

3.00

2.14

1.1

—

Childhood asthma (age<16)

5.63

2.14

1.0

—

Childhood asthma (age<16), excluding more controls

5.63

2.14

1.0

—

Focal epilepsy

2.62

2.13

1.5

1.7

—

malignant neoplasm of male genital organs

3.48

2.10

1.8

1.0

—

2.11

2.10

1.2

1.3

—

Congenital malformations of cardiac septa

3.57

2.08

2.4

—

Polyarthropathies

1.86

2.07

1.5

—

conjunctival haemorrhage

5.01

2.07

1.0

1.3

—

Speech disturbances, not elsewhere classified

5.01

2.07

1.0

1.3

—

AV-block

2.74

2.06

1.1

1.3

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

2.03

2.06

1.6

—

Malignant neoplasm of prostate

3.42

2.06

1.8

1.0

—

Atrial septal defect

4.98

2.06

2.4

1.8

—

Basal cell carcinoma

2.52

2.04

1.4

1.0

—

Systemic connective tissue disorders

2.17

2.04

1.3

—

Other diseases of arteries and capillaries

4.00

2.04

1.7

1.8

—

Bacterial, viral and other infectious agents

4.00

2.04

3.2

1.7

—

Falls/tendency to fall

131

1.61

2.02

1.3

1.5

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

3.08

2.01

1.3

1.7

—

Other diseases of pleura

2.02

2.01

1.7

1.4

—

Diseases of salivary glands

2.22

2.00

1.7

1.3

—

110

1.89

2.00

1.3

1.5

—

Other predominantly sexually transmitted diseases, not elsewhere classified

2.81

2.00

1.0

1.3

—

Peritonsillar abscess

2.81

2.00

1.0

1.6

—

Psychiatric diseases

116

1.64

1.99

1.4

1.5

—

Specific development disorders of speech and language

3.38

1.97

1.4

1.7

—

Infections with a predominantly sexual mode of transmission

2.28

1.96

1.0

1.3

—

Intracranial trauma

1.95

1.7

—

Other external causes of accidental injury

1.73

1.94

1.6

—

Pleural plaque with presence of asbestos

4.55

1.94

1.0

1.3

—

Other follicular disorders

4.55

1.94

2.0

1.7

—

Hypoglycaemia, other or unspecified

4.55

1.94

1.0

1.3

—

Other symptoms and signs involving the circulatory and respiratory systems

4.55

1.94

1.2

1.3

—

Other diseases of anus and rectum

2.35

1.93

2.3

1.6

—

Inflammatory diseases of the central nervous system

3.75

1.93

1.5

1.7

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

3.75

1.93

1.0

1.1

—

Asthma, hospital admission 2, infections

146

1.74

1.92

1.3

1.5

—

Asthma-related infections

146

1.74

1.92

1.3

1.5

—

Basal cell carcinoma, including avohilmo

2.43

1.92

1.4

1.0

—

All-cause Heart Failure

1.87

1.91

1.5

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

4.48

1.91

2.4

1.5

—

Other disorders of veins

2.10

1.89

1.0

1.4

—

Inflammatory diseases of female pelvic organs

1.88

1.4

1.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2.06

1.88

1.5

1.3

—

Lung diseases due to external agents

3.18

1.88

1.0

1.5

—

Other symptoms and signs involving cognitive functions and awareness

1.92

1.87

1.1

1.3

—

Other and unspecified iron deficiency

2.15

1.87

1.2

—

Pain and other conditions associated with female genital organs and menstrual cycle

2.67

1.86

1.4

1.1

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

2.65

1.86

1.1

1.5

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

106

1.87

1.85

1.4

—

Heart failure, strict

1.85

1.5

—

Other complications of surgical and medical care, not elsewhere classified

3.53

1.83

1.0

1.7

—

Other contact dermatitis

4.17

1.82

1.2

1.3

—

Bronchitis, not specified as acute or chronic

4.17

1.82

2.2

1.9

—

Amputation

4.17

1.82

1.0

1.2

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

2.41

1.82

1.7

1.4

—

Disorders of breast

1.98

1.82

1.1

—

Abdominal aortic aneurysm (AAA)

4.13

1.81

1.0

1.3

—

Congenital malformations of heart and great arteries

2.77

1.79

2.3

2.0

—

Infections with a predominantly sexual mode of transmission

2.05

1.78

1.1

1.4

—

Congenital malformations and deformations of the musculoskeletal system

2.75

1.77

1.3

1.8

—

Diagnoses used for exclusion with ILD

2.34

1.77

1.5

1.3

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

2.17

1.77

2.0

1.4

—

Dorsopathies

122

1.58

1.77

1.1

1.6

—

Convulsions, not elsewhere classified

3.01

1.77

1.9

1.4

—

Conjunctivitis

140

1.67

1.76

1.7

1.4

—

Car occupant injured in other and unspecified transport accidents

2.50

1.73

1.2

1.4

—

Concussion

1.95

1.73

1.8

1.7

—

Paracetamol or NSAID medication

3.78

1.73

1.0

1.4

—

Hypertrophy of breast

2.92

1.72

1.3

1.1

—

Abnormal results of function studies

3.85

1.71

1.2

1.6

—

Caries of dentine, including avohilmo

1.68

1.71

1.4

—

Other/unspecified dorsalgia

1.96

1.70

1.2

1.5

—

Substance abuse, excluding more controls

100

1.79

1.68

1.0

1.5

—

Selective serotonin reuptake inhibitors

115

1.59

1.68

1.3

1.5

—

Conductive and sensorineural hearing loss

114

1.66

1.0

1.4

—

5-aminosalicylic acid

2.58

1.65

1.1

1.4

—

Vocal cord dysfunction

3.74

1.65

1.0

1.9

—

Acute laryngitis and tracheitis

3.11

1.63

1.3

1.0

—

Caries of enamel

140

1.60

1.63

1.5

—

Sleep disorders (combined)

142

1.52

1.62

1.1

1.5

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

2.77

1.62

1.0

—

Carcinoma in situ of breast, intraductal

3.58

1.61

1.0

1.1

—

Pleural plaque

3.57

1.61

1.0

1.4

—

Other disorders of glucose regulation and pancreatic internal secretion

3.57

1.61

1.0

1.4

—

Volume depletion

3.57

1.61

1.0

1.6

—

Malignant neoplasm of digestive organs

2.39

1.61

1.3

1.0

—

Atopic dermatitis

110

1.71

1.60

1.5

1.4

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

149

1.56

1.59

1.1

1.4

—

Other predominantly sexually transmitted diseases, not elsewhere classified

2.33

1.58

1.2

1.3

—

Hyperkinetic disorders, excluding more controls

3.02

1.58

2.7

1.6

—

Superficial injury of forearm

3.00

1.58

1.2

1.5

—

Superficial injury of ankle and foot

2.69

1.58

2.0

1.5

—

Familial hypercholesterolemia

2.69

1.58

1.3

1.6

—

Presence of cardiac and vascular implants and grafts

2.18

1.57

1.0

1.2

—

Congenital malformations and deformations of the musculoskeletal system

2.68

1.57

1.3

1.8

—

Soft tissue disorders

124

1.54

1.56

1.5

—

Autoimmune diseases related-to ILD

156

1.59

1.55

1.3

1.4

—

Urticaria

2.03

1.53

2.2

1.4

—

Other and unspecified polyneuropathies, also in other diseases

2.43

1.53

1.4

1.5

—

Iridocyclitis

2.43

1.53

1.3

1.4

—

Autoimmune diseases excluding thyroid diseases

128

1.53

1.5

—

Anomalies of dental arch relationship, including avohilmo

2.25

1.53

1.1

1.6

—

Smoking dependency

3.34

1.52

1.0

1.8

—

Mental and behavioural disorders due to tobacco

3.34

1.52

1.0

1.8

—

Unspecified urinary incontinence

3.34

1.52

1.0

1.1

—

Nonischemic cardiomyopathy

3.33

1.52

2.0

1.7

—

Acute and subacute iridocyclitis

2.59

1.51

1.3

1.5

—

Secondary hypertension

3.29

1.50

1.2

1.7

—

Irritable bowel syndrome

2.16

1.50

1.3

1.4

—

Hyperplasia of prostate

2.11

1.50

1.4

1.7

—

COPD, hospital admission 2, with asthma infections

2.10

1.50

1.7

1.4

—

Deviated nasal septum

2.16

1.50

1.2

1.8

—

Viral warts

2.43

1.47

2.1

1.4

—

Diverticular disease of intestine

1.71

1.47

1.2

1.4

—

Epilepsy

1.99

1.47

1.5

1.6

—

Ovarian cyst

2.08

1.47

1.2

1.1

—

Migraine without aura and triptan purchases

2.50

1.45

1.0

1.3

—

Autoimmune diseases

129

1.50

1.45

1.6

1.5

—

Visual disturbances and blindness

117

1.71

1.44

1.7

1.3

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

2.73

1.43

1.5

—

Other metabolic disorders

2.73

1.43

1.5

—

Assault

2.73

1.43

2.3

1.1

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

2.13

1.43

2.2

1.6

—

Obesity, other/unspecified

1.97

1.43

1.2

1.3

—

Dermatitis and eczema

165

1.46

1.40

1.7

1.3

—

Other and unspecified urticaria

2.25

1.40

2.7

1.6

—

Substance abuse

118

1.67

1.39

1.0

1.5

—

Diseases of pulp and periapical tissues and dental caries

1.66

1.39

1.4

—

Injuries to the head

164

1.46

1.38

1.5

1.4

—

Obesity related asthma

1.94

1.38

1.1

1.4

—

Use of pramipexole

2.20

1.36

1.1

1.4

—

Fall on same level

150

1.46

1.36

1.4

1.5

—

Migraine with aura

2.20

1.36

1.0

1.3

—

Misadventures to patients during surgical and medical care

2.61

1.36

1.0

1.5

—

Fracture of femur

2.08

1.36

1.0

1.4

—

Disorders of gallbladder, biliary tract and pancreas

133

1.52

1.36

1.4

—

Other and unspecified drugs and medicaments

2.94

1.36

1.2

1.6

—

Heartburn

2.94

1.36

2.6

1.2

—

Peripheral artery operations in Hilmo

2.94

1.36

1.0

1.2

—

Autoimmune diseases excluding thyroid diseases, strict definition

124

1.50

1.35

1.5

—

Anti-inflammatory and antirheumatic products, non-steroids

2.26

1.34

1.6

1.5

—

Impacted teeth

2.16

1.34

1.0

1.7

—

Exposure to unspecified factor

171

1.47

1.33

1.4

1.5

—

Procreative management

1.94

1.33

1.2

1.6

—

Dental caries, including avohilmo

1.60

1.33

1.4

—

Injuries to the wrist and hand

159

1.48

1.32

1.3

1.4

—

Intestinal stricture

1.97

1.32

1.3

1.4

—

Lower back pain or/and sciatica

155

1.47

1.32

1.0

1.4

—

Inflammatory disease of uterus

2.50

1.30

1.0

1.1

—

Other disorders of patella

2.50

1.30

1.0

1.4

—

Peripheral arterial reconstruction

2.50

1.30

1.0

1.4

—

Other strabismus

2.09

1.29

1.3

1.7

—

Irregular menses

1.82

1.29

1.0

1.2

—

Certain disorders involving the immune mechanism

2.35

1.29

1.1

1.4

—

Suggestive for eosinophilic asthma

2.78

1.28

2.2

1.7

—

Allergic contact dermatitis

2.78

1.28

1.0

1.3

—

Methotrexate

2.78

1.28

1.0

1.7

—

Skin changes due to chronic exposure to nonionizing radiation

1.84

1.28

1.3

—

Colorectal adenocarcinoma

2.77

1.28

1.6

1.1

—

Primary open-angle glaucoma, strict

2.08

1.26

1.0

1.4

—

Poisoning by drugs, medicaments and biological substances

2.05

1.26

1.1

1.4

—

Primary open-angle glaucoma

1.93

1.26

1.1

1.3

—

COPD, hospital admissions 1, only main diagnosis

1.89

1.25

1.6

1.4

—

Malignant neoplasm of respiratory system and intrathoracic organs

2.77

1.25

1.2

1.0

—

Visual disturbances

107

1.68

1.25

1.8

1.3

—

Transient ischemic attack

1.67

1.25

1.5

1.3

—

Persons encountering health services in other circumstances

1.78

1.24

1.3

1.4

—

Hallux valgus (acquired)

2.12

1.24

1.1

1.4

—

Diseases of arteries, arterioles and capillaries

101

1.61

1.24

1.4

—

Polyneuropathies and other disorders of the peripheral nervous system

2.22

1.24

1.4

1.5

—

Seborrhoeic keratosis

2.22

1.24

1.1

1.3

—

Congenital malformations of the circulatory system

2.22

1.23

2.3

1.9

—

Sequelae of injuries, of poisoning and of other consequences of external causes

2.00

1.23

1.3

1.4

—

Functional dyspepsia

2.00

1.23

2.3

1.2

—

Injuries to the ankle and foot

137

1.56

1.23

1.5

—

Finngen Rheumatological endpoints

123

1.48

1.21

1.3

1.4

—

Primary hyperparathyroidism

2.63

1.21

1.0

1.2

—

Hydronephrosis

2.63

1.21

1.2

1.1

—

Other cataract

1.83

1.21

1.9

1.3

—

Disorders of refraction and accommodation

1.96

1.20

1.5

—

Open wound of wrist and hand

1.72

1.20

1.5

1.6

—

Mental and behavioural disorders due to psychoactive substance use

122

1.59

1.19

1.0

1.5

—

Disorders of eyelid, lacrimal system and orbit

148

1.49

1.19

1.5

1.3

—

Endocrine, nutritional and metabolic diseases

1.54

1.19

1.2

1.5

—

Injuries to the knee and lower leg

153

1.41

1.18

1.4

—

Retention of urine

1.89

1.17

1.1

1.5

—

Unspecified haematuria

1.75

1.17

1.3

1.5

—

Chronic rhinitis, nasopharyngitis and pharyngitis

1.93

1.16

1.4

1.5

—

Other noninfective gastroenteritis and colitis

2.00

1.16

1.0

1.7

—

Benign neoplasm of eye and adnexa

2.50

1.15

1.0

1.6

—

Thyroiditis, ILD-related definition

2.50

1.15

1.0

1.6

—

Ganglion

2.05

1.15

1.0

1.3

—

Intracerebral haemorrhage

2.50

1.15

1.8

1.4

—

Endometriosis ASRM stages 1,2

0.00

1.15

0.0

1.1

—

Dysplasia of cervi uteri

2.07

1.14

1.1

—

Other dorsopathies, not elsewhere classified

119

1.45

1.14

1.1

1.5

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

2.05

1.12

1.6

1.5

—

Dentofacial anomalies [including malocclusion]

120

1.54

1.12

1.1

1.5

—

Dysphagia

2.00

1.12

1.0

1.2

—

Atrial fibrillation and flutter

2.03

1.11

2.6

1.5

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1.99

1.11

2.3

1.8

—

Chondropathies

2.26

1.10

2.0

1.4

—

Other endocrine disorders

2.40

1.09

3.4

1.6

—

Dilated cardiomyopathy

2.38

1.09

1.8

—

Rosacea

2.38

1.09

1.8

1.6

—

Other/unspecified rheumatoid arthritis

2.38

1.09

1.0

1.2

—

Other CVD (FINNGEN)

2.42

1.08

1.2

1.7

—

Anterior Iridocyclitis

2.19

1.08

1.3

1.4

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1.94

1.07

2.3

1.7

—

Disorders of synovium and tendon

1.64

1.07

1.0

1.4

—

Maternal care for other known or suspected fetal problems

2.04

1.06

1.0

1.1

—

Other chronic obstructive pulmonary disease

1.69

1.06

1.5

1.3

—

Fall on and from stairs and steps

1.92

1.06

1.4

—

Other or unspecified ileus, impaction or obstruction

2.12

1.05

1.0

1.5

—

Crossbite

2.31

1.04

3.0

1.5

—

Dermatophytosis

121

1.57

1.04

1.1

1.4

—

Malignant neoplasm of bronchus and lung, including Hilmo

2.32

1.04

1.2

1.1

—

Restless leg syndrome

2.27

1.03

1.0

1.5

—

Erosion of teeth , including avohilmo

1.96

1.03

1.1

1.3

—

Actinic keratosis

1.74

1.03

1.2

1.3

—

Alzheimer disease, excluding more controls

2.35

1.02

1.0

1.1

—

In situ neoplasms

1.73

1.02

1.3

—

Hyperparathyroidism

2.04

1.01

1.0

1.1

—

Non-ischemic cardiomyopathy

1.84

1.01

1.5

1.6

—

Later onset COPD

1.89

1.00

1.7

1.2

—

Superficial injury of lower leg

1.88

1.00

2.2

1.3

—

Sensorineural hearing loss

104

1.50

1.00

1.0

1.4

—

Leisure time condition

2.00

1.00

1.7

1.4

—

Viral and other specified intestinal infections

1.88

0.99

2.1

1.4

—

Diseases of the myoneural junction and muscle

2.17

0.98

1.4

1.5

—

Mucosal proctocolitis

2.17

0.98

1.0

1.5

—

Other condition

2.17

0.98

2.0

1.6

—

Endometriosis of pelvic peritoneum

0.00

0.98

0.0

1.1

—

Adhesive capsulitis of shoulder

0.00

0.97

0.0

1.4

—

Diseases of liver

1.74

0.96

1.0

1.5

—

Dizziness and giddiness

130

1.46

0.96

1.1

1.3

—

Noninfective enteritis and colitis

116

1.55

0.95

1.0

1.5

—

Dermatitis

132

1.51

0.95

2.1

1.3

—

Radiculopathy

0.00

0.95

0.0

1.5

—

Superficial injury of wrist and hand

1.89

0.94

1.3

1.2

—

Fracture of rib(s), sternum and thoracic spine

1.77

0.94

1.7

1.3

—

Exclusions for E4_PCOS_BROAD

1.89

0.94

1.4

1.7

—

Injuries to the thorax

101

1.58

0.93

2.0

1.3

—

Meniscus derangement

1.61

0.93

1.2

1.6

—

COPD related to multimorbidity

1.69

0.93

1.4

—

Viral and other specified intestinal infections

1.77

0.92

2.0

1.3

—

Keratitis

1.71

0.92

1.0

1.4

—

Perineal laceration during delivery

2.18

0.92

1.0

—

Propionic acid derivatives

2.01

0.92

1.6

1.5

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1.82

0.92

1.2

1.3

—

Pulmonary heart disease

1.82

0.92

1.9

1.3

—

COPD

1.61

0.91

1.5

1.3

—

Diabetic retinopathy, strict definition

2.12

0.90

2.8

1.5

—

Excessive attrition of teeth

118

1.53

0.90

1.8

1.4

—

Disorders of thyroid, IBD co-morbidities

2.11

0.90

1.0

1.2

—

Periapical abscess

101

0.49

0.89

1.4

1.5

—

Personality disorders, excluding more controls

1.90

0.88

1.6

1.5

—

Fracture of shoulder and upper arm

1.69

0.88

1.4

1.3

—

Type of accident

1.79

0.87

1.5

1.4

—

Pulmonary embolism

1.79

0.87

1.9

1.4

—

Strabismus

1.78

0.87

1.3

1.6

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1.85

0.87

1.1

1.4

—

HSIL lesion of the cervix uteri

2.00

0.87

1.2

1.1

—

Nonorganic sleeping disorders, excluding more controls

2.00

0.87

1.0

1.5

—

Asthma, hospital admissions , main diagnosis only

171

1.39

0.86

1.2

1.5

—

Cardiac arrhythmias

1.51

0.85

1.8

1.4

—

Deep bite

1.95

0.84

1.2

1.8

—

Salpingitis and oophoritis

1.94

0.84

1.0

1.1

—

Nontoxic multinodular goitre

1.94

0.84

1.0

1.1

—

Disorders of skin appendages

112

1.52

0.84

1.5

1.3

—

Cholelithiasis, broad definition with cholecystitis

119

1.41

0.84

1.2

1.4

—

Paralytic ileus and intestinal obstruction

1.78

0.84

1.0

1.6

—

STROKE

1.55

0.83

1.9

1.4

—

COPD, hospital admissions

1.57

0.83

1.5

1.4

—

Complications predominantly related to the puerperium

1.74

0.82

1.3

1.1

—

Outcome of delivery

0.00

0.82

0.0

1.0

—

Deforming dorsopathies

1.69

0.82

1.2

1.5

—

Abrasion of teeth

1.69

0.82

1.0

1.4

—

COPD, early/later onset

1.56

0.82

1.5

1.4

—

Iron deficiency anaemia secondary to blood loss (chronic)

1.88

0.81

1.2

1.4

—

Gout, unspecified

1.88

0.81

2.5

1.4

—

Spinal stenosis

1.54

0.81

1.1

1.5

—

Asthma (diagnoses ohter than nonallergic)

170

1.37

0.81

1.2

1.5

—

Insulin, combination of fast acting with intermediate-acting or long-acting

126

1.45

0.80

1.9

1.4

—

Specific personality disorders

1.70

0.80

1.6

1.3

—

Maternal care for known or suspected fetal abnormality and damage

0.00

0.80

0.0

1.1

—

Angina pectoris

0.56

0.80

1.6

1.5

—

Other and unspecified dermatitis

114

1.49

0.79

2.4

1.3

—

Subjective visual disturbances

1.67

0.78

1.9

1.3

—

Cutaneous abscess, furuncle and carbuncle

1.67

0.78

1.1

1.5

—

Hypo-osmolality and hyponatraemia

1.81

0.78

1.3

1.5

—

Eating disorder

0.00

0.78

0.0

1.2

—

Unspecified fall

121

1.47

0.77

1.4

1.3

—

Eating disorders

0.00

0.77

0.0

1.4

—

Hyperkinetic disorders

1.78

0.77

2.7

1.2

—

Statin medication

0.62

0.76

2.0

1.4

—

Status post-ami

1.71

0.76

1.0

1.7

—

Heart failure and bmi 25plus

1.60

0.75

1.5

1.4

—

Unspecified lump in breast

2.08

0.74

1.0

1.1

—

Panic disorder

2.08

0.74

1.2

1.4

—

Phobic anxiety disorders

2.08

0.74

4.8

1.4

—

Atrial fibrillation and flutter with reimbursement

1.86

0.74

1.0

1.6

—

Colorectal cancer

2.04

0.73

1.6

1.0

—

Spondylolisthesis/Spondylolysis

1.84

0.73

1.3

1.6

—

Abnormalities of heart beat

1.63

0.73

1.1

1.3

—

Cardiomyopathies, Primary/intrinsic

2.00

0.72

1.8

1.7

—

Cardiomyopathy (excluding other)

2.00

0.72

1.8

1.7

—

Emotionally unstable personality disorder

2.00

0.72

1.0

1.5

—

Ulcerative colitis, NAS

2.00

0.72

1.0

1.5

—

Injury of eye and orbit

2.00

0.72

1.4

—

Myocardial infarction, without ST-elevation

1.56

0.72

1.0

1.5

—

Rotator cuff syndrome

1.47

0.71

1.4

—

Other arthrosis

1.54

0.71

1.6

—

Fissure and fistula of anal and rectal regions

1.75

0.71

1.1

1.6

—

Nontoxic goitre/thyroid nodule

1.58

0.71

1.0

1.1

—

Diplopia

1.92

0.70

1.2

1.5

—

Other diseases of liver

1.92

0.70

1.0

1.5

—

L02BA Anti-estrogens

1.92

0.70

1.0

1.1

—

Insulin, intermediate and long-acting

114

1.45

0.70

1.8

1.4

—

Obesity due to excess calories

101

1.49

0.70

1.1

1.4

—

Adverse effects, not elsewhere classified

1.71

0.70

1.0

1.2

—

Poisoning by medicine

1.71

0.70

1.0

1.4

—

Other and unspecified effects of external causes

1.55

0.69

1.9

1.2

—

Benign neoplasms

125

1.32

0.69

1.2

1.4

—

Pulmonary heart disease, diseases of pulmonary circulation

1.64

0.68

1.9

1.3

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1.50

0.68

1.0

1.6

—

All dysplastic lesions of the cervix uteri

1.65

0.67

1.1

—

Disorders of tooth development and eruption

1.84

0.67

1.0

1.5

—

Dislocation, sprain and strain of joints and ligaments of knee

117

1.42

0.67

1.3

1.5

—

Myocardial infarction

1.49

0.67

1.0

1.5

—

Valvular heart disease excluding rheumatic fever

1.48

0.67

1.1

1.4

—

Insulin medication

121

1.39

0.66

1.9

1.3

—

Glaucoma

102

1.43

0.66

1.4

1.3

—

Reimbursement for rheumatic diseases

127

1.41

0.66

1.4

1.3

—

Hypertension, essential

0.64

0.66

2.1

1.3

—

Generalized anxiety disorder

1.79

0.66

1.0

1.3

—

Symptoms and signs involving speech and voice

1.61

0.65

1.0

1.3

—

Disturbance of activity and attention

1.75

0.65

3.0

1.1

—

Diseases of inner ear

116

1.42

0.64

1.4

1.3

—

Other disorders of conjunctiva

1.72

0.64

1.0

1.4

—

Colectomy operation

1.72

0.64

1.6

1.5

—

Alcohol use disorder, ICD-based

1.49

0.63

1.0

1.6

—

Mouth breathing

1.49

0.62

1.8

1.6

—

Gout

1.64

0.62

2.1

1.6

—

Disturbances of skin sensation

1.63

0.62

1.0

1.4

—

Injury of muscle and tendon at shoulder and upper arm level

1.59

0.61

1.1

1.4

—

Injury of muscle and tendon at lower leg level

1.67

0.61

1.2

1.6

—

Dermatitis due to ingested food

0.00

0.60

0.0

1.7

—

Vascular dementia

0.00

0.60

0.0

1.2

—

Embedded teeth, including avohilmo

0.00

0.60

0.0

1.5

—

Other abnormal products of conception

1.56

0.60

1.0

—

Rheumatoid arthritis

1.56

0.60

1.3

1.4

—

Use of levodopa decarboxylase inhibitor

0.00

0.60

0.0

1.4

—

Acute and transient psychotic disorders

0.00

0.59

0.0

1.4

—

Other enthesopathies

1.54

0.59

1.0

1.3

—

Other disorders of ear

136

1.30

0.59

1.4

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1.53

0.59

1.3

—

Spondylopathies

103

1.33

0.58

1.1

1.5

—

Other systemic involvement of connective tissue

1.51

0.58

1.0

1.3

—

Personality disorders

1.51

0.58

1.6

1.3

—

Insomnia

144

0.71

0.58

1.0

1.4

—

Haemorrhoids and perianal venous thrombosis

1.51

0.58

1.0

1.5

—

Vasomotor and allergic rhinitis

1.52

0.57

1.1

1.5

—

Tooth eruption problems

1.72

0.57

1.7

1.4

—

Chronic lower respiratory diseases

158

1.25

0.57

1.4

1.5

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

1.71

0.57

1.0

1.4

—

HSIL lesion of the cervix uteri, vagina or vulva

1.71

0.57

1.2

1.1

—

Disorders of vestibular function (Vertigo)

1.43

0.57

1.4

1.3

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

1.67

0.56

1.2

1.5

—

Melanocytic naevi

1.45

0.56

1.3

1.4

—

Phlebitis and thrombophlebitis (not including DVT)

1.62

0.55

1.2

1.5

—

Cholecystectomy

129

1.34

0.55

1.3

—

Care involving use of rehabilitation procedures

115

0.64

0.54

1.1

1.6

—

Alcohol use disorder, Swedish definition

106

1.38

0.54

1.0

1.5

—

Early onset COPD

1.58

0.54

1.3

1.6

—

Postmenopausal atrophic vaginitis

1.58

0.54

1.3

1.1

—

Behavioural syndromes associated with physiological disturbances and physical factors

154

0.74

0.53

1.0

1.4

—

Inguinal hernia

0.67

0.53

1.6

1.5

—

Non-rheumatic valve diseases

1.42

0.53

1.1

1.5

—

Other degenerative diseases of the nervous system

1.54

0.53

1.0

1.5

—

Embedded and impacted teeth

1.53

0.52

1.0

1.5

—

Non-selective monoamine reuptake inhibitors

1.45

0.52

1.0

1.5

—

Other chronic obstructive pulmonary disease, including avohilmo

1.38

0.52

1.5

1.4

—

Major coronary heart disease event

117

1.29

0.52

1.2

1.6

—

Cerebrovascular diseases

112

1.32

0.52

1.6

1.3

—

Mental and behavioural disorders due to alcohol

104

1.39

0.52

1.0

1.5

—

Nonorganic sleeping disorders

1.50

0.51

1.0

1.4

—

Persons encountering health services in circumstances related to reproduction

1.36

0.51

1.2

1.7

—

Arthrosis

1.35

0.50

1.4

1.5

—

Intracranial injury

136

1.32

0.50

1.5

—

Fracture of lower leg, including ankle

108

1.37

0.50

1.2

1.4

—

Atopic dermatitis, strict definition with reimbursement

1.38

0.50

2.0

1.3

—

Gout, idiopatic and unspecified

1.46

0.50

2.5

1.5

—

Congenital malformations, deformations and chromosomal abnormalities

129

1.33

0.49

1.7

1.5

—

Other extrapyramidal and movement disorders in other diseases

1.56

0.48

1.3

1.4

—

Biguanides

137

0.76

0.48

1.5

1.3

—

Fracture of foot, except ankle

1.52

0.48

1.1

1.3

—

Colonic or urogenital fistula

1.52

0.48

1.1

1.4

—

Injuries to the neck

1.49

0.47

1.3

—

Fibroblastic disorders

1.49

0.47

1.4

1.3

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1.49

0.47

1.3

—

Percutaneous Coronary Intervention

110

1.28

0.47

1.2

1.6

—

Seropositive rheumatoid arthritis

1.48

0.47

1.3

—

Congenital malformations, deformations and chromosomal abnormalities

134

1.31

0.47

1.7

1.5

—

Persons with potential health hazards related to communicable diseases

1.42

0.47

1.1

1.4

—

Cholelithiasis

118

1.28

0.47

1.2

1.4

—

Coronary revascularization (ANGIO or CABG)

110

1.28

0.47

1.2

1.6

—

Benign neoplasm: Colon, unspecified

1.46

0.46

1.3

1.5

—

IBD patients in KELA-register

1.46

0.46

1.0

1.3

—

Other/unspecified seropositive rheumatoid arthritis

1.46

0.46

1.3

—

Open wound of head

124

1.32

0.46

1.5

—

Ulcerative colitis

1.43

0.46

1.0

1.4

—

Seropositive rheumatoid arthritis, wide

1.43

0.46

1.3

—

All dysplastic lesions of the cervix uteri, vagina or vulva

1.41

0.45

1.1

—

Inflammatory bowel disease, strict (require KELA)

1.40

0.45

1.0

1.3

—

Coxarthrosis [arthrosis of hip](FG)

1.35

0.45

1.1

1.4

—

Other systemic involvement of connective tissue (FG)

1.38

0.44

1.0

1.3

—

Chronic gastritis

1.37

0.44

1.9

1.2

—

Dislocation, sprain and strain of joints and ligaments at neck level

1.61

0.43

1.4

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

1.61

0.43

1.0

1.4

—

Emergency coronary revascularization (for ACS)

122

1.25

0.42

1.2

1.6

—

Benign lipomatous neoplasm

1.43

0.42

1.0

1.5

—

Gout, FINNGEN

1.42

0.42

2.1

1.4

—

Other disorders of eyelid

0.65

0.42

1.7

1.2

—

Ulcerative colitis (strict definition, require KELA)

1.56

0.42

1.0

1.4

—

Thyrotoxicosis, other and/or unspecified

1.56

0.42

1.0

1.3

—

Disorders of adult personality and behaviour

1.40

0.42

1.6

1.3

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1.38

0.41

1.1

1.3

—

Other specified/unspecified hearing loss

0.00

0.41

0.0

1.3

—

Retained placenta and membranes, without haemorrhage

0.00

0.41

0.0

1.0

—

Excessive vomiting in pregnancy

0.00

0.41

0.0

1.1

—

Ankylosing spondylitis, ICD10

0.00

0.41

0.0

1.7

—

Amiodarone users

0.00

0.41

0.0

1.2

—

Other congenital malformations of skin

0.00

0.40

0.0

1.5

—

Abnormal findings on antenatal screening of mother

0.00

0.40

0.0

1.0

—

Other shoulder lesions

0.00

0.40

0.0

1.6

—

0.00

0.40

0.0

1.1

—

Respiratory and cardiovascular disorders specific to the perinatal period

0.00

0.40

0.0

2.4

—

Psoriasis vulgaris

1.47

0.40

2.0

1.4

—

Dementia in Alzheimer disease

1.46

0.40

1.0

1.1

—

Asthma/COPD (KELA code 203)

158

1.21

0.40

1.3

1.5

—

Carbimazole or st.post thyroidectomy, condition for graves disease

1.43

0.39

1.6

1.3

—

Cardiomyopathy

1.43

0.39

1.8

1.7

—

Deep endometriosis

0.00

0.39

0.0

1.1

—

Subarachnoid haemorrhage

0.00

0.39

0.0

1.6

—

Aortic aneurysm

1.40

0.38

1.0

1.6

—

Any dementia, excluding more controls

1.32

0.37

1.0

1.3

—

Inflammatory bowel disease

1.32

0.37

1.0

1.4

—

Nontraumatic intracranial haemmorrhage

1.35

0.37

1.8

1.3

—

Other intervertebral disc disorders

107

1.24

0.36

1.1

1.5

—

Fall on same level involving ice and snow

125

1.28

0.36

1.3

—

Contraceptive management

1.40

0.36

1.2

1.6

—

Injuries to the hip and thigh

1.31

0.36

1.1

1.4

—

Sequelae of cerebrovascular disease

1.27

0.36

1.0

1.2

—

113

1.28

0.36

1.0

1.5

—

118

1.27

0.36

1.0

1.5

—

Shoulder lesions

1.25

0.36

1.6

1.4

—

Pregnancy hypertension

0.65

0.36

1.0

1.1

—

Paroxysmal tachycardia

1.43

0.35

1.0

1.6

—

Complications of labour and delivery

1.30

0.35

1.1

—

Unstable angina pectoris

0.62

0.35

1.0

1.6

—

Heart failure and antihypertensive medication

1.40

0.35

1.2

1.6

—

Other respiratory disorders and diseases

1.40

0.35

1.0

1.5

—

Other diseases of the respiratory system

1.40

0.35

1.0

1.5

—

Extrapyramidal and movement disorders

1.37

0.34

1.2

1.3

—

Sulfasalazine

1.36

0.34

1.0

1.4

—

severe traumatic brain injury, does not include concussion

1.36

0.34

1.2

1.4

—

Fracture of lumbar spine and pelvis

1.36

0.34

1.3

1.4

—

Sleep disorders

145

0.80

0.34

1.0

1.4

—

Thyrotoxicosis

1.33

0.33

1.0

1.3

—

Suicide or other Intentional self-harm

1.33

0.33

1.2

1.4

—

Other arrhythmias

102

1.26

0.33

1.3

1.4

—

Pure hypercholesterolaemia

1.25

0.33

1.6

1.4

—

Major coronary heart disease event excluding revascularizations

1.26

0.33

1.0

1.5

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1.34

0.33

1.8

1.4

—

Pollen allergy

1.29

0.32

1.2

1.5

—

Coxarthrosis

1.32

0.32

1.1

1.5

—

Hypertension

0.78

0.32

2.5

1.3

—

Hypertensive diseases

0.78

0.32

2.5

1.3

—

Gastroduodenal ulcer

1.32

0.30

1.4

1.3

—

Leiomyoma of uterus

1.28

0.30

1.0

1.1

—

Primary coxarthrosis, bilateral

1.27

0.30

1.0

1.5

—

Other maternal disorders predominantly related to pregnancy

0.75

0.30

1.1

—

Diabetes, varying definitions

146

1.16

0.28

1.8

1.3

—

Varicose veins

1.26

0.28

1.4

—

Striking against or struck by other objects

1.31

0.28

1.8

1.6

—

Diabetes mellitus

146

1.16

0.28

1.8

1.3

—

Urolithiasis

1.27

0.27

1.1

1.5

—

Alzheimer disease

1.25

0.27

1.0

1.1

—

Lumbar disc prolapse

0.77

0.27

1.2

1.5

—

Glucosamine medication

1.28

0.27

1.0

1.4

—

Sulfonylureas

0.67

0.26

1.6

1.3

—

Internal derangement of knee

1.19

0.26

1.0

1.6

—

Retinal detachments and breaks

0.67

0.25

1.0

1.4

—

Excessive earwax

120

1.22

0.25

1.0

1.4

—

Rheumatoid arthritis, including avohilmo

1.18

0.24

1.2

1.3

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

0.72

0.24

1.0

1.1

—

Postpartum haemorrhage

1.36

0.23

1.0

—

Dementia

0.76

0.23

1.3

1.2

—

Benign neoplasm: Colon

110

1.21

0.23

1.4

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

1.25

0.22

1.2

1.3

—

Asthma, including avohilmo

170

1.12

0.22

1.2

1.5

—

Fracture of skull and facial bones

1.19

0.21

1.2

1.4

—

Acute nasopharyngitis (common cold)

0.00

0.21

0.0

1.8

—

Cyst of Bartholin Gland

0.00

0.21

0.0

1.0

—

Gluteal tendinitis

0.00

0.21

0.0

1.1

—

Maternal care for known or suspected disproportion

0.00

0.21

0.0

1.1

—

Unspecified abortion

0.00

0.21

0.0

1.1

—

Foreign body in respiratory tract

0.00

0.21

0.0

1.0

—

Other secondary gonarthrosis

0.00

0.21

0.0

1.3

—

Contact with heat and hot substances

0.00

0.21

0.0

1.8

—

Bullous disorders

0.00

0.21

0.0

1.3

—

Hypermobility syndrome

0.00

0.21

0.0

1.0

—

Congenital malformations of the urinary system

0.00

0.21

0.0

1.3

—

Desensitization to allergens

0.00

0.21

0.0

1.0

—

L04AC Interleukin inhibitors

0.00

0.21

0.0

1.7

—

Calcific tendinitis of shoulder

0.00

0.21

0.0

1.9

—

Endovascular or surgical operations to intracerebral aneurysms

0.00

0.21

0.0

1.1

—

Cyst of kidney

0.00

0.21

0.0

1.3

—

Emphysema

0.00

0.21

0.0

1.3

—

Tubulo-interstitial nephritis, not specified as acute or chronic

0.00

0.21

0.0

1.0

—

Amenorrhoea

0.00

0.21

0.0

1.1

—

Endometriosis of rectovaginal septum and vagina

0.00

0.21

0.0

1.1

—

Congenital malformations of the urinary system

0.00

0.21

0.0

1.5

—

Viral hepatitis

0.00

0.21

0.0

1.7

—

Schizoaffective disorder

0.00

0.21

0.0

1.8

—

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

0.00

0.21

0.0

1.0

—

Fall on and from ladder

0.00

0.21

0.0

1.8

—

Gonarthrosis [arthrosis of knee](FG)

1.18

0.20

1.1

1.5

—

Female genital prolapse

1.26

0.20

1.2

1.1

—

Cerebrovascular diseases (FINNGEN)

1.25

0.20

1.7

1.4

—

Insulin, fast-acting

1.25

0.20

2.0

1.4

—

Inflammatory disease of cervix uteri

0.00

0.20

0.0

1.1

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

0.00

0.20

0.0

1.1

—

Other and/or unspecified nontoxic goitre

0.00

0.20

0.0

1.0

—

Persons encountering health services for specific procedures, not carried out

0.00

0.20

0.0

1.6

—

Ankylosing spondylitis

0.00

0.20

0.0

1.9

—

Brachial plexus disorders

0.00

0.20

0.0

1.6

—

Other eating disorders

0.00

0.20

0.0

1.3

—

Anorexia (incl.atypical)

0.00

0.20

0.0

1.3

—

KRA_PSY_EATING, excluding more controls

0.00

0.20

0.0

1.3

—

Alzheimer’s disease (Late onset)

1.23

0.20

1.0

1.1

—

Diseases of male genital organs

1.21

0.19

2.3

1.6

—

Any dementia

1.24

0.18

1.0

1.2

—

Calculus of kidney and ureter

1.17

0.17

1.1

1.6

—

Artificial joint operation, meniscal resection

132

1.13

0.17

1.2

1.4

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

1.14

0.16

1.1

—

Delivery, wide proxy

0.78

0.16

1.0

—

Cervical disc disorders

1.14

0.16

1.0

1.7

—

Degenerative diseases of the nervous system

1.11

0.16

1.0

1.2

—

Fracture of forearm

119

0.85

0.15

1.0

1.4

—

Other and unspecified disorders of vitreous body

0.76

0.15

2.3

1.4

—

Medical abortion

1.16

0.15

1.2

1.1

—

Carpal tunnel syndrome

114

0.85

0.15

1.3

1.4

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

0.79

0.14

1.1

—

Type 2 diabetes, definitions combined

127

1.11

0.14

1.6

1.2

—

Type 2 diabetes

132

1.11

0.14

1.9

1.2

—

Appendectomy

133

0.86

0.14

2.7

1.3

—

Type 2 diabetes, wide definition

108

1.13

0.14

2.3

1.3

—

Degeneration of macula and posterior pole

1.16

0.13

1.3

—

Disorders of lipoprotein metabolism and other lipidaemias

1.13

0.13

1.6

1.4

—

Spondylosis

0.83

0.13

1.2

1.6

—

Coronary atherosclerosis

0.87

0.12

1.0

1.6

—

Ischaemic heart disease, wide definition

100

1.11

0.11

1.0

1.5

—

Type 2 diabetes, strict (exclude DM1)

129

1.09

0.11

1.6

1.2

—

Diseases of appendix

151

0.90

0.11

2.7

1.2

—

Stroke, including SAH

0.88

0.11

1.4

1.3

—

Insulin, fast-acting or short human

1.16

0.10

2.0

1.5

—

Postpartum hemorraghe, parous women as controls

1.15

0.10

1.0

1.1

—

Myocardial infarction, unclassifiable

1.14

0.10

1.0

1.5

—

Stomatitis and related lesions

1.14

0.10

3.2

1.5

—

Postpartum hemorraghe, all women as controls

1.12

0.10

1.0

1.1

—

Type 2 diabetes, definitions combined, including avohilmo

129

1.08

0.09

1.6

1.2

—

Appendicitis, broad definition

150

0.90

0.09

2.7

1.2

—

Superficial injury of head

1.04

0.09

1.0

1.2

—

Alzheimer’s disease, strict definition

1.12

0.09

1.0

1.1

—

Organic, including symptomatic, mental disorders

0.88

0.09

1.2

1.4

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

0.88

0.09

1.1

1.2

—

Other hearing loss

1.09

0.08

1.7

1.4

—

Type 1 diabetes

1.07

0.08

2.3

1.4

—

Diabetes mellitus in pregnancy

0.80

0.08

1.0

1.1

—

Symptoms and signs involving the nervous and musculoskeletal systems

136

1.10

0.08

1.3

1.4

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

0.77

0.08

1.0

—

Use of memantine

0.83

0.08

1.0

1.1

—

Use of other anti-dementia drugs

0.83

0.08

1.0

1.1

—

Gonarthrosis, primary, with knee surgery

0.89

0.08

1.2

1.4

—

N06DA Anticholinesterases

0.80

0.07

1.3

1.2

—

Use of anticholinesterases

0.80

0.07

1.3

1.2

—

Fracture at wrist and hand level

0.84

0.07

1.0

1.6

—

Kela-code for severe mental illness

0.82

0.07

1.0

1.4

—

Pregnancy with abortive outcome

1.10

0.07

1.2

1.1

—

Contact with and exposure to communicable diseases

1.09

0.07

1.1

1.4

—

Atopic dermatitis, strict definition

1.07

0.07

1.1

1.5

—

Allergic rhinitis

1.07

0.07

1.1

1.5

—

Delivery

0.84

0.07

1.1

1.0

—

Alzheimer disease, including avohilmo

1.02

0.07

1.0

1.2

—

Stroke, excluding SAH

1.10

0.07

1.4

1.3

—

Unspecific neurodegenerative disorder

0.87

0.07

1.3

1.2

—

Other symptoms and signs involving the nervous and musculoskeletal systems

1.12

0.06

1.3

1.4

—

Hernia

151

1.06

0.06

1.3

1.4

—

Hernia of abdominal wall

0.85

0.06

1.8

1.4

—

Acute appendicitis, no complications

121

0.90

0.06

2.5

1.2

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

135

0.94

0.06

2.1

1.3

—

Benign neoplasm of colon, rectum, anus and anal canal

120

1.09

0.06

1.4

1.3

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

103

1.09

0.05

2.2

1.2

—

Coxarthrosis, primary

109

1.09

0.05

1.1

1.4

—

Diabetes, insulin treatment (Kela reimbursement)

147

0.94

0.05

2.0

1.3

—

Other (not insulin) diabetes medications

132

0.94

0.05

1.7

1.2

—

Other retinal disorders

116

1.07

0.05

1.7

1.4

—

Ischemic heart diseases

113

1.06

0.05

1.2

1.6

—

Coxarthrosis, primary, with hip surgery

1.08

0.03

1.1

1.4

—

Injuries to the elbow and forearm

150

1.05

0.03

1.1

1.5

—

Temporomandibular joint disorders, including avohilmo

1.08

0.02

1.1

1.2

—

Dementia, including avohilmo

1.07

0.01

1.2

1.3

—

Disorders of choroid and retina

133

0.96

0.01

1.6

1.4

—

Nerve, nerve root and plexus disorders

151

0.97

0.01

1.1

1.4

—

Myocardial infarction, strict

1.06

0.00

1.0

1.6

—

Exclusions for E4_PCOS_CONSORTIUM

1.01

0.00

1.0

1.3

—

Acute appendicitis

145

0.97

0.00

2.7

1.2

—

Gonarthrosis,primary

120

1.03

0.00

1.1

1.4

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

105

1.02

0.00

1.1

1.3

—

Ischaemic Stroke, excluding all haemorrhages

0.97

0.00

1.2

1.3

—

Hard cardiovascular diseases

119

1.00

0.00

1.4

1.6

—

Primary gonarthrosis, bilateral

0.97

0.00

1.2

1.4

—

Sciatica+with lumbago

0.98

0.00

1.0

1.6

—

Artrosis, including avohilmo

104

1.00

0.00

1.4

1.5

—

Gonarthrosis

1.02

0.00

1.0

1.6

—

Abnormal findings on examination of blood, without diagnosis

0.97

0.00

2.2

1.4

—

Necrosis of pulp, including avohilmo

126

1.03

0.00

1.0

1.4

—

Allergic conjunctivitis

117

1.00

0.00

1.1

1.3

—

Diabetes medication

152

1.01

0.00

1.9

1.3

—

LeFortI or BSSO operation

0.00

0.0

1.0

—

Vascular dementia (subcortical)

0.00

0.0

1.0

—

Monoarthritis, not elsewhere classified

0.00

0.0

1.0

—

Pterygium

0.00

0.0

1.6

—

Vascular syndromes of brain in cerebrovascular disorders

0.00

0.0

1.4

—

Other viral hepatitis

0.00

0.0

1.9

—

Vitamin deficiency, wide

0.00

0.0

1.0

—

Gonococcal infection

0.00

0.0

1.0

—

Pustulosis palmaris et plantaris

0.00

0.0

1.1

—

Disorders of vitreous body

0.91

0.00

2.1

1.4

—

Bicuspidal aortic valve syndrome

0.00

0.0

2.1

—

Other and unspecified iridocyclitis

0.00

0.0

1.0

—

Gestational diabetes (for exclusion)

0.93

0.00

1.0

1.1

—

Viral hepatitis, IBD co-morbidity

0.00

0.0

1.0

—

Short Achilles tendon (acquired)

0.00

0.0

1.0

—

Other orthopaedic follow-up care

0.00

0.0

1.0

—

Laparoscopic right hemicolectomy

0.00

0.0

1.3

—

Other fall from one level to another

0.93

0.00

2.2

1.5

—

Hyperfunction of pituitary gland

0.00

0.0

1.0

—

Female infertility, tubal origin

0.00

0.0

1.2

—

Other and unspecified disease of Bartholin gland

0.00

0.0

1.0

—

Hyperlipidaemia, other/unspecified

0.98

0.00

1.1

1.4

—

Endometriosis

0.86

0.00

1.0

1.1

—

Voice disturbances

0.96

0.00

1.0

1.4

—

Other salmonella infections

0.00

0.0

1.0

—

Biomechanical lesions, not elsewhere classified

0.00

0.0

1.4

—

Vitamin deficiency

0.00

0.0

1.0

—

Bilateral sagittal split ramus osteotomy operation

0.00

0.0

1.0

—

Other obstetric conditions, not elsewhere classified

0.93

0.00

1.0

—

Moderate visual impairment, binocular

0.00

0.0

1.0

—

Papulosquamous disorders

0.99

0.00

1.6

1.3

—

Glaucoma suspect

0.90

-0.00

1.8

1.3

—

Recurrent dislocation and subluxation of joint

0.00

-0.00

0.0

2.1

—

Hypertensive diseases (excluding secondary)

0.97

-0.00

2.3

1.3

—

Other specified disorders of muscle

0.00

-0.00

0.0

2.3

—

Polyp of the female genital tract

0.99

-0.00

1.0

1.1

—

Inguinal of femoral hernia, unilateral

0.00

-0.00

0.0

1.0

—

All dysplastic lesions of the vulva

0.00

-0.00

0.0

1.0

—

Unspecified mental disorder

0.92

-0.00

1.0

1.6

—

Sleep disorders, other/unspecified

0.00

-0.00

0.0

1.0

—

Chronic nephritic syndrome

0.00

-0.00

0.0

1.0

—

Anankastic personality disorder

0.00

-0.00

0.0

1.0

—

Femoral hernia, unilateral

0.00

-0.00

0.0

1.0

—

Asthma mixed form (mode), excluding more controls

0.00

-0.00

0.0

1.2

—

Pervasive developmental disorders excl. Autism + Asperger

0.00

-0.00

0.0

1.0

—

Chronic viral hepatitis

0.00

-0.00

0.0

2.0

—

Abscess of Bartholin gland

0.00

-0.00

0.0

1.0

—

Pemphigoid

0.00

-0.00

0.0

1.0

—

Other specified/unspecified dorsopathies

0.00

-0.00

0.0

1.0

—

Other pulmonary heart/vessel disease

0.00

-0.00

0.0

1.3

—

Infections of breast associated with childbirth

0.00

-0.00

0.0

1.0

—

1.00

-0.00

1.5

1.2

—

Other demyelinating diseases of the central nervous system

0.00

-0.00

0.0

1.0

—

Systemic lupus erythematosus

0.00

-0.00

0.0

1.0

—

Other disorders of male genital organs

0.00

-0.00

0.0

2.3

—

Ectropion of eyelid

0.00

-0.00

0.0

1.0

—

Labour and delivery complicated by umbilical cord complications

0.00

-0.00

0.0

1.0

—

Bulimia nervosa (incl. atypical)

0.00

-0.00

0.0

1.0

—

Pustular psoriasis

0.00

-0.00

0.0

1.0

—

Polypectomy (DHB20)

0.00

-0.00

0.0

2.2

—

Carcinoma in situ of other and unspecified sites

0.00

-0.00

0.0

1.6

—

Systemic atrophies primarily affecting the central nervous system

0.00

-0.00

0.0

1.7

—

LSIL lesion of the vulva

0.00

-0.00

0.0

1.0

—

Hypertrichosis

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Rectosigmoid junction

0.00

-0.00

0.0

1.5

—

Crohn disease (strict definition, all UC cases excluded)

0.00

-0.00

0.0

1.0

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Disorders of puberty, all

0.00

-0.00

0.0

2.0

—

Other and unspecified disorders of psychological development

0.00

-0.00

0.0

1.2

—

UC patients in KELA-register (code 208), prior to 1994

0.00

-0.00

0.0

1.0

—

Dislocation, sprain and strain of joints and ligaments of thorax

0.00

-0.00

0.0

1.0

—

Lesion of sciatic nerve

0.00

-0.00

0.0

1.4

—

Disorders of vitreous body and globe

0.91

-0.00

2.1

1.4

—

Polyhydramnios

0.00

-0.00

0.0

1.1

—

Hemiplegia

0.00

-0.00

0.0

1.0

—

Premature separation of placenta [abruptio placentae]

0.00

-0.00

0.0

1.0

—

Benign neoplasm: other/unspecified salivary gland

0.00

-0.00

0.0

1.0

—

Other benign neoplasm of uterus: Other parts/unspecified

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Skin of ear and external auricular canal

0.00

-0.00

0.0

1.0

—

Carcinoma in situ of other and unspecified digestive organs

0.00

-0.00

0.0

1.6

—

Benign neoplasm: Small intestine

0.00

-0.00

0.0

1.0

—

Volvulus

0.00

-0.00

0.0

1.0

—

Umbilical hernia

0.88

-0.00

2.2

1.5

—

Injuries involving multiple body regions

0.00

-0.00

0.0

1.0

—

Vertical strabismus

0.00

-0.00

0.0

1.0

—

Obsessive-compulsive disorder

0.00

-0.00

0.0

1.0

—

Other and unspecified abdominal hernia

0.00

-0.00

0.0

1.0

—

SLE (Finngen)

0.00

-0.00

0.0

1.0

—

Inguinal hernia, unilateral

0.00

-0.00

0.0

1.0

—

Sixth [abducent] nerve palsy

0.00

-0.00

0.0

1.0

—

Ankylosing spondylitis, strict definition

0.00

-0.00

0.0

2.3

—

Malignant neoplasm of ovary

0.00

-0.00

0.0

1.0

—

Disorders of puberty

0.00

-0.00

0.0

2.0

—

Other benign neoplasms of uterus

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of ovary, including Hilmo

0.00

-0.00

0.0

1.0

—

Hyperprolactinaemia

0.00

-0.00

0.0

1.0

—

Congenital malformations of the respiratory system

0.00

-0.00

0.0

1.0

—

SLE, strict definition

0.00

-0.00

0.0

1.0

—

Systemic lupus erythematosus, unspecified

0.00

-0.00

0.0

1.0

—

Other epidermal thickening

0.00

-0.00

0.0

1.5

—

Hidradenitis suppurativa

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Conjunctiva

0.00

-0.00

0.0

1.0

—

Diabetic retinopathy

0.87

-0.00

3.2

1.5

—

Pacemaker

0.87

-0.00

1.0

1.3

—

Other and unspecified degenerative diseases of nervous system

0.00

-0.00

0.0

1.0

—

Acute alcohol intoxication ICD-9

0.00

-0.00

0.0

1.0

—

Toxic effect of contact with venomous animals

0.00

-0.00

0.0

1.0

—

Use of selegiline

0.00

-0.00

0.0

1.4

—

Use of levodopa decarbox-comt-inhibitor

0.00

-0.00

0.0

1.6

—

Generalized epilepsy

0.00

-0.00

0.0

1.0

—

Mild mental retardation

0.00

-0.00

0.0

1.3

—

Other/unspecified soft tissue disorders related to use, overuse and pressure

0.00

-0.00

0.0

1.0

—

Use of ropinirole

0.00

-0.00

0.0

1.5

—

Congenital malformations of the respiratory system

0.00

-0.00

0.0

1.0

—

Primary ovarian failure

0.00

-0.00

0.0

1.0

—

Other benign neoplasms of skin

0.91

-0.00

1.1

1.4

—

Melanoma in situ

0.00

-0.00

0.0

1.3

—

Other, unspecified and serous retinal detachments

0.00

-0.00

0.0

1.0

—

Other surgical follow-up care

0.00

-0.00

0.0

1.0

—

Cramp and spasm

0.00

-0.00

0.0

1.0

—

Cystic kidney disease

0.00

-0.00

0.0

1.0

—

Carcinoma in situ of skin of upper limb, including shoulder

0.00

-0.00

0.0

1.0

—

Primary angle-closure glaucoma

0.00

-0.00

0.0

1.0

—

Complications of genitourinary prosthetic devices, implants and grafts

0.00

-0.00

0.0

1.0

—

Asthma mixed form (mode)

0.00

-0.00

0.0

1.2

—

Oesophagitis

0.00

-0.00

0.0

1.0

—

Psoriasis

0.93

-0.00

2.0

1.4

—

Viral conjunctivitis

0.00

-0.00

0.0

1.0

—

0.00

-0.00

0.0

1.0

—

Hypertrophic cardiomyopathy

0.00

-0.00

0.0

1.4

—

Benign paroxysmal vertigo

0.98

-0.00

2.0

1.3

—

Complications of the puerperium, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Secondary right heart disease

0.00

-0.00

0.0

1.0

—

Artificial opening status

0.00

-0.00

0.0

1.8

—

Pedestrian injured in collision with pedal cycle

0.00

-0.00

0.0

1.0

—

Hypertensive Renal Disease

0.00

-0.00

0.0

1.0

—

Embolic stroke

0.00

-0.00

0.0

1.0

—

Contact with other hot fluids

0.00

-0.00

0.0

1.0

—

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

0.00

-0.00

0.0

1.0

—

Symptoms and signs involving emotional state

0.00

-0.00

0.0

1.0

—

Impingement syndrome of shoulder

1.02

-0.00

2.0

1.3

—

Sub-endpoint used in defining T1D endpoints

0.88

-0.00

2.3

1.5

—

Other symptoms and signs involving general sensations and perceptions

0.00

-0.00

0.0

1.0

—

Gonococcal infection

0.00

-0.00

0.0

1.0

—

Other specified/unspecified inflammatory spondylopathies

0.00

-0.00

0.0

1.9

—

Spontaneous abortion

1.00

-0.00

1.1

—

Prepatellar bursitis

0.00

-0.00

0.0

2.0

—

Dislocation, sprain and strain of joint and ligaments of hip

0.00

-0.00

0.0

1.0

—

Other assisted single delivery

0.00

-0.00

0.0

1.0

—

Maternal care for cervical incompetence

0.00

-0.00

0.0

1.0

—

Other congenital malformations of skin

0.00

-0.00

0.0

1.0

—

Single spontaneous delivery

0.99

-0.00

1.1

1.0

—

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

0.00

-0.00

0.0

1.2

—

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

0.00

-0.00

0.0

2.0

—

Other aneurysm

0.00

-0.00

0.0

1.4

—

Other secondary coxarthrosis

0.00

-0.00

0.0

1.0

—

Recurrent dislocation of patella

0.00

-0.00

0.0

1.0

—

Panniculitis affecting regions of neck and back

0.00

-0.00

0.0

2.3

—

Other salmonella infections

0.00

-0.00

0.0

1.0

—

SLE, ICD10

0.00

-0.00

0.0

1.0

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Human metapneumovirus Ag [Presence] in Specimen

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS